BCAT1 Antikörper (AA 1-386)
Kurzübersicht für BCAT1 Antikörper (AA 1-386) (ABIN5541706)
Target
Alle BCAT1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 1-386
-
Aufreinigung
- Protein-A affinity chromatography
-
Immunogen
- Recombinant human BCAT1 (1-386aa) purified from E. coli.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- The antibody has been tested by ELISA, Western blot analysis to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Liquid. In Phosphate-Buffered Saline ( pH 7.4) with 0.02 % Sodium Azide, 10 % Glycerol.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer. Avoid repeated freezing and thawing. Shelf life: one year from despatch.
-
Haltbarkeit
- 12 months
-
-
- BCAT1 (Branched Chain Amino-Acid Transaminase 1, Cytosolic (BCAT1))
-
Andere Bezeichnung
- bcat1
-
Hintergrund
- BCAT1, also known as branched chain amino-acid transamise (cytosolic form), catalyzes the reversible transamition of branched-chain alpha-keto acids to branched-chain L-amino acids essential for cell growth. Two different clinical disorders have been attributed to a defect of branched-chain amino acid transamition: hypervalinemia and hyperleucine-isoleucinemia. BCAT1 is expressed in the brain and kidney. Overexpressed in MYC-induced tumors such as Burkitt's lymphoma.
-
UniProt
- P54687
Target
-